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Abstract in English 
Health care expenditures in industrial countries have been growing rapidly over the past forty 
years. This rapid growth jeopardizes the sustainability of public budgets and causes an 
increasing interest in the determinants of health care expenditures. The first purpose of this 
paper is to give an up to date overview of the literature on health care expenditures. Secondly, 
this paper tries to contribute to the existing literature by investigating the impact of several 
factors on health care expenditures in an empirical analysis using an error-correction model. 
Additional to the ‘usual suspects’ for rising health care expenditures, we pay attention to a 
somewhat neglected driving factor, which is the increase in the relative price of health care 
compared to other goods and services. We find that the increasing price of health care helps to 
explain the increase in real health care expenditures. However, the use of health care in volume 
terms is negatively affected by the increasing price. This effect seems to be stronger in periods 
of cost containment policy. Consistent with most recent findings in the literature, we find that 
income and ageing are important drivers of health care expenditures.  
 
Key words: health care expenditures, error-correction model 
 
JEL code: I100, H510 
 
Abstract in Dutch 
De zorguitgaven in de industriële landen zijn de afgelopen veertig jaar sterk gegroeid. Deze 
sterke groei vormt een bedreiging voor de houdbaarheid van de publieke budgetten en 
veroorzaakt een toenemende belangstelling voor de determinanten van de zorguitgaven. Dit 
paper geeft ten eerste een up-to-date overzicht van de bestaande literatuur over zorguitgaven. 
Daarnaast beoogt dit paper een bijdrage te leveren aan deze literatuur door het effect van 
verschillende factoren op de zorguitgaven in een empirische analyse te onderzoeken met behulp 
van een error-correctiemodel. Naast de bekende determinanten van stijgende zorguitgaven 
richten we ons hierbij op de invloed van de relatieve prijs van zorg. We vinden dat de stijgende 
relatieve prijs van zorg bijdraagt aan de stijgende zorguitgaven. Het effect van de relatieve prijs 
op de volumes van zorggebruik is echter negatief. Dit effect lijkt sterker te zijn in een periode 
van kostenbeheersing. In overeenstemming met recente onderzoeksresultaten vinden we dat 
inkomen en vergrijzing belangrijke determinanten zijn van de stijgende zorguitgaven.  
 
Steekwoorden: zorguitgaven, error-correctiemodel 
   4   5 
Contents 
Summary  7 
1  Introduction  9 
2  Overview of the literature  11 
2.1  Introduction  11 
2.2  Important drivers of health care expenditures  12 
2.3  Conclusions from the literature  20 
3  Data  21 
4  Method and model  25 
5  Estimation Results  27 
6  Conclusions  31 
References  33 
Appendix A   List of variables  36 
Appendix B   Construction of relative prices  37 
   7 
Summary 
Health care expenditures in industrial countries have been growing rapidly over the past forty 
years. This rapid growth jeopardizes the sustainability of public budgets and causes an 
increasing interest in the determinants of health care expenditures. In the literature many factors 
are proposed as possible drivers of health care expenditures. The first purpose of this paper is to 
give an up to date overview of the literature on health care expenditures. From this we conclude 
that income, ageing and some institutional variables are important in explaining health care 
expenditures growth. 
Secondly, this paper tries to contribute to the existing literature by investigating the impact 
of several factors on health care expenditures in an empirical analysis using an error-correction 
model. Additional to the common factors that are proposed in the literature, we pay attention to 
a somewhat neglected driving factor, which is the increase in the relative price of health care 
compared to other goods and services.  
The estimation results suggest that there is a stable long run relationship between health care 
expenditures on the one hand and GDP, age structure of the population and the relative price of 
health care on the other hand. The relative price has a significant impact on health care 
expenditures in the long run and for most countries -among which the Netherlands - also in the 
short run. We find coefficients which imply that an increase in price decreases volume and 
increases real health care expenditures in the long run. Furthermore, the estimation results, 
though uncertain, suggest that the impact of the price was larger (in absolute value) during the 
period 1980-2003. This could be explained by the strong cost containment policy during this 
period, in which budgets are fixed and prices have less influence on expenditures.  
Consistent with most recent findings in the literature, we find that income and ageing are 
important drivers of health care expenditures. The income elasticity is significantly positive and 
just below unity. It takes values of 0.93 and 0.96, which corresponds well to the existing 
literature. Ageing turns out to have a positive impact on health care expenditures, while both the 
coefficients of the population aged between 65 and 74 and the population aged above 75 are 
significantly positive.  
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1  Introduction 
Health care expenditures (HCE) in industrial countries have been growing rapidly over the past 
forty years. In most countries expenditures on medical treatment tend to increase faster than 
gross domestic product (GDP). This rapid growth brings an improvement in life expectancy and 
quality of life, but also jeopardizes the sustainability of public budgets.
1 A particular concern 
for the next decades is that the ageing of the population may increase the expenditures on health 
care even more. This causes an increasing interest in the determinants of health care 
expenditures. Interestingly, the impact of ageing as such on health care expenditures is the 
subject of considerable debate. For example, the proponents of the cost of dying-hypothesis 
maintain that the last period of life is expensive in terms of health care, not so much ageing as 
such. 
The research for this paper was carried out mostly as part of the AHEAD project (Ageing, 
Health Status and Determinants of Health Expenditure). This is a research project 
commissioned by the European Commission and carried out in the Enepri-network which 
focuses on the future evolution of health care expenditures in the European Union. This paper 
investigates the determinants of health care expenditures by both collecting recent insights from 
the existing literature and by carrying out an empirical analysis.  
In the literature, many factors are proposed as possible drivers for health care expenditures. 
Gerdtham and Jönnson (2000) provide an overview of the literature on international 
comparisons of health care expenditures. They conclude that income is the most important 
variable. Other factors which are often used to explain health care expenditures are ageing, 
medical technology, health status of the population and some institutional variables. 
The first purpose of this paper is to provide an up to date overview of the literature on 
international comparisons of health care expenditures. This gives an insight in the most 
important variables to be used in estimating and projecting health care expenditures. The 
selection of papers to review is based on the choice of explanatory variables, econometric 
methods used (especially regarding stationarity and cointegration issues), theoretical insights 
and recentness. 
Furthermore, this paper aims to contribute to the existing literature by investigating the 
determinants of health care expenditures in an empirical analysis. We focus on a not commonly 
used variable: the relative price of health care. This price tends to increase over time because of 
the Baumol effect. This may decrease the demand for health care in terms of volume. Omitting 
the relative price in the set of explanatory variables may lead to biased coefficients for the other 
variables. Therefore, taking the relative price into account can be a valuable extension to most 
research done so far. Due to a lack of good data available, relative prices are constructed out of 
a series of prices and wages. 
 
1 See for example Cutler (2004) for the benefits of health care expenditures.   10 
Many health economists use a fixed effects model for panel data analyses of health care 
expenditures. In the recent literature more attention is paid to topics like structural breaks and 
cointegration. Some drivers of health care expenditures are likely to have a unit root which may 
cause spurious regressions. To deal with non-stationarity of the variables we therefore adopt an 
error correction model.  
The structure of this paper is as follows. Chapter 2 provides an overview of the literature on 
international health care expenditures. Chapter 3 introduces the variables to be studied and 
describes the data. It addresses the construction of data on the relative price. Chapter 4 
discusses the research methodology and the model choice. The estimation results are presented 
in chapter 5. Chapter 6 summarizes the main findings and concludes. 
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2  Overview of the literature 
2.1  Introduction 
In one of the first cross section analyses of macro expenditures, Newhouse (1977) found that 
92% of the variance in health care expenditures between countries could be explained by gross 
domestic product and that the income elasticity was larger than one. Since then, much research 
along those lines has been done, using cross-sectional data as well as time series and panel data. 
Gerdtham and Jönsson (2000) present an overview of the extensive literature on international 
comparisons of health care expenditure. They find that the most important factor explaining 
variations in health care expenditures is aggregate income. The effect of gross domestic product 
is positive and significant and close to unity or higher than unity. The effect of the population 
age structure is usually insignificant. The same holds for the less frequently used variables as 
unemployment rate and female labour participation. A number of institutional variables seem to 
be important too. For example, when the primary care sector acts a gatekeeper, the expenditures 
are lower. They also claim that the many macro-econometric analyses of health care 
expenditures lack a solid theoretical foundation.  
There are several reasons why one should be careful in interpreting the results of macro 
analyses. First of all, there are data problems. Despite the effort put into it, time series are 
usually not fully comparable between countries, especially regarding the definition of long term 
care. A more basic problem is the difficulty of reliably measuring the volume of health care. 
Usually there are no market prices that can be used, only regulated or constructed prices. It is 
very difficult to properly correct for quality advances and improvements in the organisation of 
care. Secondly, there is the question whether pooling of countries or states is acceptable. There 
are many indications that the relevant restrictions will be rejected, if tested (see Roberts (1999), 
Ariste and Carr (2003), Murillo et al. (1993), O’Connell (1996), Clemente et al (2004).) On the 
other hand, in making projections the results on pooled data may still be superior. Baltagi and 
Griffin (1997) show for gasoline consumption that pooling leads to higher quality long-run 
forecasts. They conclude: ‘Using a root mean square error criterion, the efficiency gains from 
pooling appear to more than offset the biases due to intercountry heterogeneities.’(p. 317).  
Finally, the stationarity of the data is questioned. With non-stationary data spurious results 
may be found. Roberts (2000) remarks on this point: ‘In summary the regression of non-
stationary variables is likely to result in a spurious regression problem, by which the apparent 
close correlation between health care expenditure and, for example, per capita income is the 
result of common trends rather than evidence of any real economic relationship. ….. In the 
special case where a linear combination of non-stationary variables is itself stationary, then this 
combination represents the cointegrating, or long-run, relationship, which can be specified in 
levels, with short-run dynamics modelled via an error correction process.’ The issue of the best 
possible analysis of most likely non-stationary data in this area has not yet been settled.    12 
In the past 10 years, many researchers carried out different tests for stationarity and 
cointegration (see for example Gerdtham and Jönsson (2000) for an overview of earlier results, 
Dreger and Reimers (2005), Okunade and Murthy (2002), Gerdtham and Löthgren (2002), 
Clemente et al (2004), Jewell et al (2003)and Okunade et al (2004) ). Some of these researchers 
allowed for the possibility of structural breaks in the data which appears to give different results 
on stationarity. Below we will give much attention to the creation of a useful time series model 
for health care expenditures.  
2.2  Important drivers of health care expenditures 
Table 2.1 gives a brief summary of estimation results of various studies for a number of 
important variables or groups of variables. In accordance with Gerdtham and Jönsson (2000) we 
find gross domestic product per capita to be an important explanatory factor in these analyses, 
but unlike these authors we find many income elasticities to be lower than one, especially in 
recent studies. Also, in contrast to their findings, ageing was associated with higher health care 
expenditures in many recent studies. Proxies for the introduction and diffusion of new medical 
technology (mostly simple trends) usually have a positive significant effect on health care 
expenditures. Some researchers also use institutions and the relative price of health care in their 
attempts to explain the development of health care expenditures.  
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Table 2.1  Summary of parameters estimation results (across various models with different specifications) 
  GDP  Ageing  Relative 
price 
health 






               
Christiansen 
et al (2006) 
0.56   not significant 
in the final 
specification 
  positive 
significant 
1,5%  0.009  significant 
OECD (2006)  0.87  significant 
positive 
    2% for 70’s 
1.3 and 1%  for 
80s and 90s 
   
Ligthart (2006)  0.72 - 0.99  significant 
positive 




0.68 - 0.84  significant 
positive 
  proxies e.g. 
share of the 
elderly 
     











    − 0.13  significant 
Clemente et al 
(2004) 




      different constant 
and income el. in 
most countries 
after break 
   
Ariste and 
Carr (2003) 
0.88  not significant      2%     
Okunade and 
Murthy (2002) 
1.56 - 1.64      positive 
significant effect 
of R&D 
     
Roberts 
(1999) 









0.66 - 0.82  negative, not 
very 
significant 
  positive 
significant  
    significant 
Barros (1998)  0.62 - 0.92 
(growth) 









0.53  significant 
positive 
    HCE in 1990 
26% higher than 
1975 
− 0.11   
Murthy and 
Ukpolo (1994) 





    0.78   
Murillo et al 
(1993) 




       
   14 
The relative price of health care has generally been increasing in the past decades. This may be 
one of the factors underlying the increase in real health care expenditures, unless the higher 
relative price was offset by lower volumes. We start by discussing the role of the relative price. 
After that, income, ageing, technology and institutions will be discussed. 
Relative prices 
The health care sector is labour-intensive and it is possible that labour productivity thus 
increases less fast than it does in other sectors of the economy (Baumol, 1967). However, wages 
in the health care sector have to be in line with the rest of the economy over the longer run in 
order to be able to attract enough labour. Therefore, it likely that health care becomes relatively 
more expensive over time. Okunade et al (2004) show that the relative prices of health care, for 
a large number of OECD countries, increased in every sub-period from 1968 till 1992. Only in 
the period 1993-1997 it decreased. This increase in the relative price of health care may affect 
the volume of health care demand and the real health care expenditure. The volume can be 
expected to decrease. The real expenditures may increase if health care is a (relatively) price- 
inelastic good. There may be differences in the relative price of health care between countries 
(at the same moments in time), due to differences in policies with respect to the regulation of 
prices, or differences in labour supply.  
In many studies, the relative price is not included in the set of explanatory variables. This 
means that other estimated coefficients may be biased if the series are correlated with the 
relative price. Murillo et al (1993) express health care expenditures in volume terms and find 
negative price-elasticities for nine European countries in practically all of their estimated 
models. Most of the estimated elasticities are smaller than 1 in absolute sense. This means that 
real health care expenditures (deflated by the price of GDP) increase when the relative price 
increases. This is also what Okunade et al (2004) find for the growth of real health care 
expenditures for OECD countries. Murthy and Ukpolo (1994) on the other hand find a long-run 
negative effect of the relative price on real health care expenditures for the USA, A 1% increase 
in relative price leads to a -0.22 % decrease in real health care expenditures. This means that the 
volume of health care expenditures is decreased by about 1.2% and it seems to indicate that the 
volume of health care expenditures is price-elastic. It is possible that the macro-price elasticity 
is larger (in absolute terms) in the USA than in Europe. Roberts (1999) finds positive long-run 
elasticities for real health care expenditures smaller than one for relative prices in 4 out of 5 
estimated models for 20 OECD-countries. In a cross-section analysis of OECD countries, 
Gerdtham and Jönsson (1991) find a price-elasticity of -0.84 for the volume of health care (and 
an income elasticity of 1.43). The available evidence for OECD-countries seems to suggest that 
an increase in the relative price of health care causes larger real health care expenditures and a 
lower volume of health care. 
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The role of income 
The overview of Gerdtham and Jönsson (2000) shows that gross domestic product is the single 
most important variable used to explain health care expenditures in macro-studies. We could 
ask ourselves why that would be the case. As national income increases we want to have nicer 
houses, better holidays, more new clothes and perhaps better public services. But we might not 
become ill more often, so why would we want to have more health care? Health care is not a 
service that we consume because it is fun to consume. We just want to become healthy or stay 
healthy. One possible explanation for the effect of income is that we would have liked to have 
more health care before but decided we could not afford it with a lower national income. In 
other words, there was an unmet need for health care.   
Another explanation is that we wish to spend more on health care because new technology 
opens up wonderful new possibilities. Hall and Jones (2004) expand on this explanation. They 
study the share of health care in income with the help of a theoretical model in which utility 
depends upon consumption and health status and they formulate a health production function. 
They conclude that technological development alone is not enough to explain an increasing 
share of health care in income. The technology not only has to be available to buy, but people 
should also want to buy it. The reason that they might want that is that the marginal utility of 
consumption decreases as they get richer. The marginal utility of spending extra money on 
health care may also decrease, but not as fast. There are indications that the value of a statistical 
life increases over time at a faster rate than the growth of gross domestic product. Their 
estimation results indicate that the marginal costs of saving a life also increase over time (from 
1950 to 2000). Technological progress in itself is not a crucial factor in explaining a rising share 
of health care in their model, as in the simple version of the model progress may even decrease 
the optimal health share depending on the form of the health production function. A relatively 
fast decrease of the marginal utility of consumption is crucial. Hall and Jones (2004) formulate 
it as follows: ‘In summary, our basic model suggests that the health share rises over time as 
income grows if the joy associated with living an extra year does not diminish as quickly as the 
marginal utility of consumption (p. 11).’ Their model might help to explain why a large effect 
of income on health care expenditures may be found.  
All the studies summarized in table 2.1 find a significant positive effect of income. 
However, some estimation results may be biased because of omitted variables that may be 
correlated with gross domestic product. Researchers who ignore the influence of technological 
change or positive trends in general may overestimate the income elasticity. Hence, a proper 
econometric model linking health care expenditures with income should cover the trend in the 
right way.  The same applies to studies where relative prices from the equation are omitted as 
long as the relative price for health care increases and the price-elasticity of real health care 
expenditures is positive.  
Usually researchers who include a trend or some proxy for technological development find 
income elasticities lower than one. Exceptions are Roberts (1999) and Okunade and Murthy   16 
(2002). Roberts finds high income elasticities, mostly positive price elasticities and a negative 
trend. The negative trend is surprising. Okunade and Murthy (2002) include health R&D or 
total R&D as an indication for technological development but still find high income elasticities 
for the USA. Their estimate of the income elasticity may be biased upwards because they omit 
the relative price. 
The evidence might indicate that the ‘true’ income elasticity, that would be found when all 
relevant explanatory variables are included, is smaller than one. Another explanation for the 
recent results is that the income elasticity decreased over time. An interesting question in the 
light of the discussion above is whether larger health care expenditures are actually caused by 
higher gross domestic product. Devlin and Hansen (2001) test for Granger-causality between 
gross domestic product and health care expenditures for 20 OECD-countries. For 6 countries 
health care expenditures ‘cause’ gross domestic product
2, for 6 countries gross domestic 
product causes health care expenditures and for 2 countries the causality works both ways. For 
6 countries no causality is found. They warn that this result is dependent on the choice for 
bivariate equations; multivariate equations might give different results. It is remarkable that the 
causality from gross domestic product to health care expenditures that is implicitly assumed in 
many analyses is only found for 6 countries.  
Ageing 
Gerdtham and Jönsson (2000) conclude that generally not much effect of ageing is found in 
international comparisons of health care expenditures. In contrast to their findings, many of the 
studies summarized in table 2.1, especially the most recent ones, do find a significant and 
positive effect of ageing on health care expenditures.  
At first sight, one would expect a positive effect of ageing on health care expenditures as 
older people use much more health care than younger people. However, Zweifel (1999) has 
tried to show that this pattern is mostly associated with the high cost of dying and the fact that 
older people have a larger probability of dying. An overview of the literature on death related 
costs is given in Raitano (2005). His findings can be summarized as follows. Health care costs 
of decedents are much higher than those for survivors. Costs in the last period of life decrease 
with age. The age pattern for long term care is different than that for health care. Econometric 
studies show for people over 65 that proximity to death has a larger effect on health care 
expenditures than age. There is still uncertainty about the residual influence of age once 
proximity to death is taken into account. Projection studies that distinguish between decedents 
and survivors all find a lower increase in health care expenditures, but the reduction differs 
significantly among studies. Raitano’s final conclusion is that ‘age alone is not a good predictor 
of health spending growth, and that proximity to death must also be used as a predictor of health 
care expenditure.’ (p. 19). 
  
 
2 Health care expenditures can increase human capital.    17 
Hence, a positive effect of ageing on health care expenditures is not inconsistent with the 
literature on death-related costs. But in making projections the effect of proximity to death 
should not be ignored. 
Christiansen et al. (2006) find different effects for both the proportion of the population 
aged 65-74 and the proportion aged 75+ for the 15 old EU countries, depending on the model 
specification. In the most extensive model, in which country fixed effects, a time trend and 
many institutional variables are included the effect of the age structure is insignificant.  Dreger 
and Reimers (2005), Okunade et al. (2004) and O’Connell (1996) find a positive and significant 
effect for the share of the population over 65 for OECD countries. Ligthart (2006) shows a 
similar result for the old EU countries. Murthy and Ukpolo (1994) find a large positive effect of 
the share over 65 for the USA. In contrast, Gerdtham et al (1998) find a positive effect on health 
care expenditures for the share of ages 0-4 and a slight negative effect for people over 75. The 
OECD (2006) finds a positive effect of the average population age on health care expenditures. 
Influence of technology/trends 
The results of Gerdtham and Löthgren (2002) indicate that a trend should be included in the 
long term relation between health care expenditures and gross domestic product. Given the 
chosen variables their model cannot explain the growth of health care expenditures without an 
independent trend. Researchers who allow for trends in real health care spending over time 
practically always find a positive trend despite the fact that gross domestic product is included 
as an explanatory variable (see OECD(2006), Ligthart (2006), Ariste and Carr (2003), Freeman 
(2003) and O’Connell (1996)), where Roberts (1999) is an exception. The cost-increasing effect 
of technological change in health care is often given as an explanation (see Weisbrod, 1991). 
Technological change in health care may have cost-saving effects as in many other sectors. 
However, an important effect is that conditions become treatable that were previously not or 
badly treatable or not treatable for frail patients. New treatment options may be added to the old 
ones instead of substituted. Patients who would have died earlier are kept alive, but often not 
completely cured. Their chronic conditions have to be treated for a long time. New drugs are 
often very expensive. The consensus seems to be that technological change brings us saved life-
years and improved quality of life, but also on balance increases in the costs of health care (see 
Cutler, 2004).  
The role of technology may become clearer by including proxies for technological 
development in the model instead of just trends. Okunade and Murthy (2002) include health 
R&D or total R&D as proxies for technological development in a time series analysis for the 
USA (cointegration estimation). R&D has a positive and significant effect on health care 
expenditures. They state (p. 157): “Our findings confirm, econometrically for the first time in 
this line of inquiry, the untested conjecture that changes in R&D spending, a proxy for changes 
in technology, is a statistically significant long-run driver of rising health care expenditure.” 
Dreger and Reimers (2005) consider life expectancy, infant mortality and share of the elderly as   18 
possible proxies for medical progress. Their cointegration analysis yields the expected signs for 
these variables, which are included in the equation for health care expenditures one by one. 
However, their role as proxies for medical progress seems to be not beyond doubt, especially 
for the share of the elderly. This is probably in many countries influenced more by the post war 
baby boom and the drop in fertility than by medical progress. Infant mortality and life 
expectancy are not just influenced by medical progress, but also by health behaviour, 
environmental factors, hygiene, and so on. Gerdtham et al (1998) include the number of renal 
dialyses per million of the population as a proxy and find a positive significant effect. 
Christiansen et al (2006) also find a positive effect of such proxies. All in all there seems to be 
some evidence that technological progress can explain the positive trends in health care 
expenditure. This explanation seems to be plausible. The complementary view of Hall and 
Jones (2004) on the role of technology was discussed in the section on income. Their model 
suggests that technological progress by itself is not enough to explain a rising share of health 
care in GDP. It has to be combined with a relatively fast decrease of the marginal utility of 
consumption. 
Institutions and supply of health care 
Christiansen et al (2006), Gerdtham et al (1998), Roberts (1999), Murthy and Ukpolo (1994), 
O’Connell (1996) and Okunade et al (2004) all find a significant effect of institutions on health 
care expenditures. Barros (1998) finds no significant results. In some analyses only the share of 
public financing in health care is included. It is not a priori clear which sign this variable should 
have. Leu (1986) expected a positive sign because bureaucrats try to maximize their budgets 
and there is less competition in the public sector. An alternative explanation is that a larger 
share of public financing makes it possible to increase the number of people insured or the 
coverage which will lead to higher health care expenditures because of moral hazard effects. On 
the other hand, competition in the private sector may not be very successful in controlling cost 
growth because of large information asymmetries and the presence of health insurance. It may 
be easier to contain costs in the public sector and there may also be a larger incentive because of 
worries about an increase of government share in gross domestic product.  
The empirical work does not give a clear answer as positive as well as negative signs are 
found in different studies. Okunade et al (2004) find a negative sign for the share of public 
financing not only for their panel data estimates but also for about every sub-period, except 
1973-1977.  
Okunade et al (2004) and Gerdtham et al (1998) classified health systems as public 
integrated, public contract or public reimbursement. In a public integrated system, one 
organisation controls funding as well as the provision of care (for example the NHS in the 
United Kingdom). In a contract system, third party payers negotiate with health care providers 
and patients should in principle use providers that are under contract with their insurer. In a 
reimbursement system, consumers have free choice of providers and providers are reimbursed   19 
by patients or their insurers. One would expect that it is easiest to control the growth of costs in 
a public integrated system and a public contract system after that. Gerdtham et al (1998) find 
lower health care expenditures under public reimbursement than under public integrated 
systems in all of their estimated models, which is surprising. They find their results for public 
reimbursement systems difficult to explain. A possible explanation is that public integrated 
systems have higher shares of in-patient care, which is expensive, and they also have fewer 
gate-keeping arrangements. Okunade et al (2004) find for four of the six sub-periods that a 
public integrated system lowered the growth of health care expenditures, but the overall effect 
in the panel data models is positive and significant. The public reimbursement system is 
associated with a higher growth of health care expenditures, not just for the whole period, but 
also for every sub-period. 
 The effect of overall ceilings for hospitals on health care expenditures is positive in 
Gerdtham et al (1998). This may be a selection effect. Countries with high growth of health care 
expenditures may decide to maximize hospital costs. Gerdtham et al. (1998) find a positive 
effect of the share of in-patient care in total health care on health care expenditures and a 
positive effect of public insurance coverage. For gate keeping, a negative effect was found. 
Okunade et al (2004) find different effects for different sub periods for gatekeeping. Gerdtham 
et al (1998) find a negative effect for capitation and for capitation in combination with wages 
and salaries compared to fee-for-service systems. In Christiansen et al. (2006), salaried general 
practitioners (GP’s) and GP’s with capitation payment are associated with lower health care 
expenditures compared to GP’s under a fee-for-service system. According to Okunade et al 
(2004) capitation in the primary care sector leads to higher health care expenditures growth over 
the whole period (significantly lower in 1988-1992). According to Christiansen et al. (2006) 
case-based reimbursement of hospitals leads to lower health care expenditures. 
 All in all, institutions seem to matter for health care expenditures but the evidence on the 
precise effect of institutions is confusing and inconclusive. 
In a market where demand is formulated independently from supply, one would expect that 
an increase in supply decreases the price and -in case of an inelastic good- decreases 
expenditures. However, in the health care market supplier-induced demand is a possibility that 
is extensively discussed in the literature. If the supplier-induced demand hypothesis is valid (or 
health care is elastic) a positive sign for the number of doctors per capita may be found. The 
evidence from macro studies on this point is conflicting. Okunade et al (2004) find a positive 
effect of the number of physicians on health care expenditures, while Christiansen et al (2006) 
find a negative effect. Murthy and Ukpolo (1994) find an important negative effect of the 
number of doctors and advise policy makers to train more doctors. Gerdtham et al (1998) find a 
negative effect of the supply of physicians in itself, but a positive effect in combination with a 
fee-for-service system. Christiansen et al (2006) find a positive sign for the number of acute 
care beds.   20 
Health and behaviour 
A more healthy behaviour may lower the growth of health care expenditures over the long run, 
but this does not necessarily have to be the case. For example, not-smoking might keep people 
from dying from lung cancer at a comparatively young age, with as a consequence that they 
have a larger probability of suffering from chronic diseases associated with ageing. Taking 
health behaviour into account is difficult with commonly available data, as lags between 
behaviour and health effect may be very long. A person who starts smoking now, may get lung 
cancer in 30 years from now. Christiansen et al (2006) and Gerdtham et al (1998) both find that 
tobacco consumption is associated with higher health care expenditures. In addition, they both 
find no significant effect of alcohol consumption. 
2.3  Conclusions from the literature 
Income and technology are both important drivers of health care expenditure. The influence of 
these two factors is difficult to unravel. Without an increase in income it is difficult to spend 
more on new medical technology, but without new technology in the end there will be no 
reason to want more health care per capita, unless morbidity is increasing. 
 The effect of ageing is significant in many recent studies. Despite the high cost of dying, 
ageing as such also seems to increase health care expenditures over time. This seems especially 
likely for the costs of long-term care. However, institutions are also important for these costs. In 
countries with a traditionally high institutionalisation rate costs increases may be curbed by a 
new organisation of long term care. With respect to institutional variables we generally 
conclude that they seem to matter, but their effect is not a priori clear. The rise in relative prices 
of health care may help to explain the increase in health care expenditure.  
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3  Data 
From the literature review, we conclude that more attention should be paid to the relative price 
of health care as driver for health care expenditures. This section discusses the data we will use 
in our empirical analysis below, where we pay particular attention to the construction of relative 
prices.  
To study which factors affect health care expenditures and to what extent, we make use of a 
macro panel data set. The main data source used for this research is the OECD Health Data 
2005. At our disposal we have (unbalanced) panel data on health care expenditures, income, 
ageing, and the public share of health care expenditures of the old 15 EU countries for the 
period 1970-2003. We analyse health care expenditures for the 8 countries for which the data 
are most extensive and these are Austria, Finland, Ireland, Luxembourg, the Netherlands, 
Portugal, Spain and the United Kingdom. 
An overview of all variables used in the models can be found in Appendix A. We will use 
real health care expenditures as the dependent variable. Note that for the estimation results it 
makes no difference whether this variable is used or the purchasing power parity- and inflation 
corrected health care expenditures (see box at the end of this section).  
 The OECD Health Data set does not provide data on the relative price of health care. To 
analyse the influence of the relative price, we have constructed series for the relative prices of 
health care out of series of wages and a consumer price index. This construction method is 
discussed in appendix B. We have added these constructed series of the relative price for each 
country to the OECD data to complete our data set. 
To verify the constructed price of health care we have compared it with the available CPI-
health data from the OECD Health Data. This source contains CPI-health data for three of the 
countries under consideration. Figure 3.1 presents the CPI-health for the available countries and 
our constructed prices (price indices with base year 2000).   22 
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Figure 3.1 shows that our constructed prices are reasonably close to the health CPI data. This 
gives confidence about the reliability of our data on relative prices. 
 
By deflating all constructed prices for health care by the GDP price, we obtain the relative 
health care prices for each country. The developments of the relative prices per country for each 
of the 8 countries under consideration are displayed in figure 3.2. For about all countries, the 
constructed relative price of health care has increased between 1970 and 2003. Only Ireland is 
an exception.   23 
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The use of purchasing power parities 
 
In order to find out which factors influence health care expenditures, most studies make use of a macro data set and 
estimate various linear models. Total health care expenditures are almost always used as the dependent variable. These 
expenditures can be decomposed in volumes of demand and prices. Basically, we are interested in the impact of various 
variables on the volume. 
 
Unfortunately, however, because of a lack of good data on volumes and prices we cannot directly distinguish between 
them. Hence, confusion between prices and quantities may easily arise, for example because of the use of market 
exchange rates to convert HCE and GDP into a common unit, like Newhouse (1977) did. This inadequate distinction 
between volumes and prices could be the explanation for the high income elasticity he found.  Often, researchers use 
purchasing power parities (PPP’s) to partly avoid this problem and convert the expenditures into a common unit.  
 
The overall price level as well as the price level for health care (a basket of health care goods and services) can differ 
across countries and fluctuate over time. PPP’s correct for differences in overall price levels between countries. To adjust 
PPP-corrected  expenditures  for  overall  price  levels  over  time,  one  has  to  deflate  with  GDP  prices  of  the  reference 
country. For example, if health care expenditures for a number of countries are given in US $ PPP’s (after correction for 
inflation differences between countries), they have to be deflated with the US GDP price to correct for inflation over time. 
This PPP-corrected and inflation-corrected health care expenditure is frequently used by researchers as a dependent 
variable. Notice that with respect to the estimation results it makes no difference whether PPP- and inflation-corrected 
expenditures are taken as dependent variable or just real health care expenditures for each country (expenditures of 
each country deflated with its own GDP price). The only use of PPP’s is to convert the expenditures to a common 
currency  which  makes  series  comparable  across  countries.  For  the  estimation  results  there  is  no  additional  use  in 
converting expenditures to PPP’s. 
 
Differences in real health care expenditures (or PPP-corrected and inflation-corrected health care expenditures) between 
countries or over time still reflect not only differences in the volume of health care but also differences in the relative price 
of health care.
a 
As discussed in section 2.2, the relative price of health care compared to other goods and services, 
defined as the price of health care deflated with the GDP price, can vary over time and across countries. Therefore, 
including the relative price of health care in the set of explanatory variables makes it possible to make a clear distinction 
between prices and volumes. 
 
a
 A possible solution to avoid this is to use a basket of health care goods and services to determine PPP’s. In that case the PPP-corrected 
values have to be deflated with the price of health care in the reference country to correct for differences in health care prices over time. 
Then, differences in the ‘health PPP’-corrected and ‘inflation in health care’ corrected HCE reflect only differences in volumes. However, 
reliable health PPP’s are difficult to construct and are rarely used in analyses. 
   25 
4  Method and model 
We have annual time series data for 8 countries and these data concern: 
 
HCEi,t               = real health care expenditure per capita for country i at time t 
GDPi,t               = real gross domestic product per capita for country i at time t 
POP65_74i,t      = proportion of population aged 65-74 for country i at time t 
POP75i,t            = proportion of population aged above 75 for country i at time t 
PUBLICi,t         = public share of total health care expenditures for country i at time t 
PRICEi,t            = relative price of health care in country i at time t. 
 
Tests for unit roots on the individual series indicate that for most series we cannot reject the 
relevant null hypothesis.
3 Most series show an upward trending pattern and it is now of interest 
to see if these trends are somehow similar, or put otherwise, whether there is cointegration 
across these variables. 
The sample size is too small to perform a 6-variable multivariate test for cointegration. The 
power of such a test in this case is extremely low. Hence, we do not pursue along these lines. 
Another issue is that we are basically interested in the properties of a single cointegration 
relationship (should one exist), and this concerns the long-term link between expenditures and 
the other five variables. So, our model below shall contain a single variable linking the levels of 
the data. In addition, as we have annual data, current growth rates of the explanatory variables 
are likely to be correlated with current growth rates in expenditures. Finally, to increase the 
power of the statistical analysis on the long-run relationship, and also following the suggestions 
of Baltagi and Griffin (1997), we impose that it is the same across the 8 countries under 
scrutiny. Together this leads to the 8-equation model: 
 
log (HCEi,t) − log (HCEi,t− 1)  =  βi1 + βi2 [ log (HCEi,t− 1) − β3 log (GDPi,t− 1) −   
β4 log (POP65_74i,t−1 ) −  β5 log  (POP75i,t−1 ) − β6 log (PUBLICi,t− 1) −  β7 log (PRICEi,t− 1) ] +  
βi8 (log (GDPi,t) − log (GDPi,t− 1)) + βi9 (log (POP65_74i,t) − log (POP65_74i,t− 1))  + 
βi10 (log (POP75i,t) − log (POP75i,t− 1)) + βi11 (log (PUBLICi,t) − log (PUBLICi,t− 1)) + 
βi12 (log (PRICEi,t) − log (PRICEi,t− 1)) + εi,t                                (4.1)                                                                   
 
for i = 1,2,..,8.  
 
To examine if there is a relevant cointegration relation in this so-called conditional error 
correction model, one can test the significance of the adjustment parameters βi2, see Boswijk 
(1994). This means that one tests for the joint significance of log (HCEi,t− 1), log (GDPi,t− 1), log 
 
3 Details can be obtained from the authors.    26 
(POP65_74i,t−1 ), log  (POP75i,t−1 ), log (PUBLICi,t− 1) and log (PRICEi,t− 1) in the linearized 
version of model (4.1).  
 
After estimation of model (4.1) with seemingly unrelated regression (SUR), we proceed by 
dropping all statistically insignificant current growth rates of the explanatory variables to obtain 
our final model. 
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5  Estimation Results 
This section presents the results of the cointegration test and the estimation results of the error 
correction models for two different time periods.
4  
 
The results for the Wald test for cointegration and the estimated adjustment parameters βi2 are 
given in table 5.1. 
Table 5.1  Wald test results and adjustment parameters ECM by country, 1970-2003 
Country  Wald test  Coefficient  Standard Error  Number of periods T after which 
95% of shock has died out 
         
Austria  39.34  − 0.205  0.083  13 
Finland  28.44  − 0.051  0.023  57 
Ireland  65.99  − 0.318  0.055  8 
Luxemburg  37.95  − 0.504  0.098  4 
Netherlands  33.13  − 0.254  0.053  10 
Portugal  17.54  − 0.317  0.100  8 
Spain  32.90  − 0.516  0.101  4 
United Kingdom  10.84  − 0.206  0.070  13 
 
The critical value of the Wald test is 25.66 at the 5% level and 20.19 at the 20% level. 
 
For Austria, Finland, Ireland, Luxemburg, Netherlands and Spain we find clear evidence of 
cointegration. For the United Kingdom and Portugal the evidence is less clear. However, given 
the limited number of observations we choose to leave these countries in our pooled model.  
Clearly, the estimated adjustment parameters have the proper sign and, assuming that there is a 
single cointegration relation for all 8 countries, the parameters are all unequal to zero. The 
adjustment parameters can be interpreted in terms of the number of periods it takes before a 
shock has died out to a certain extent. Table 5.1 presents the number of periods T, which is 
defined as the 95% duration interval of a shock to the equilibrium relation (due to for example 
increased income or higher prices). In other words, after T periods 95% of the shock has died 
out. The table shows that there is a wide variation in the 95% duration interval among the 
countries considered. In reality of course we never observe a new long run equilibrium because 
the driving factors keep on changing. 
 
The long-run cointegration relation parameters are given in table 5.2. 
 
4 We have also examined the 8 series of estimated residuals, but find no signs of serious misspecification.   28 
Table 5.2  Estimation results ECM long run  1970-2003 
Variable  Coefficient  Standard Error  T-statistic 
       
Log (GDP)   0.934  0.039  24.14 
Log (POP65_74)   0.267  0.085   3.16 
Log (POP75)   0.472  0.078   6.06 
Log (PUBLIC)              − 0.191  0.124              − 1.54 
Log (PRICE)   0.684  0.133  5.15 
 
The t-statistic of these parameters is not distributed as standard t, but still, the obtained values 
suggest confidence in the relevance of all but one variable (log(PUBLIC)) in the long-run 
relation. The coefficient of GDP is close to but less than unity. The age composition of the 
population is also important with a larger impact of the older population group (over 75) on the 
development of expenditures. An increase in the relative price of health care is associated with a 
less than proportionate increase in real expenditures. This means that, in the long run, part of 
the increase in relative prices is “compensated” by a decrease in the volume of health care 
consumed. 
Table 5.3   Estimation results ECM short run by country, 1970-2003 
  Log(PRICE)  Log(POP75)  Log(PUBLIC) 
       
Austria  3.687    −  1.029 
Finland  1.204  0.574  0.762 
Ireland       
Luxemburg  0.540  0.203   
Netherlands  0.869     
Portugal  0.997    −  0.286 
Spain      −  0.308 
United Kingdom      1.180 
 
Another interesting question is which factors influence health care expenditures in the short run. 
Table 5.3 presents the estimation results of the short run coefficients that are part of our final 
model for each of the countries. All of these coefficients are significant at a 5% level. From the 
estimation results it follows that especially changes in the relative price of health care and the 
share of public financing are important in the short run. The large positive effect of changes in 
the relative price seems to suggest that in the short run these changes mostly lead to an increase 
in real health care expenditures. For Austria, Finland, Portugal and the Netherlands the short 
run impact of price changes is somewhat larger than the long run impact.  
For the Netherlands, the direct effect of a temporary 1% increase in the relative price of 
health care is an increase in real health care expenditures of 0.87%. In the next period and the 
periods after real health care expenditures are somewhat decreased because of the error 
correction mechanism. After 10 periods the cumulative effect of a 1% increase in the relative 
price is 0,69% increase in real health care expenditures. After an infinite number is periods the   29 
cumulative effect would be equal to the long run parameter: 0,68%. So the long run effect is 
somewhat smaller than the direct effect for the Netherlands. For most other countries (except 
Luxemburg)  the difference between short and long run effects of a change in relative price is 
much larger. 
From 1980 on, in many countries a more severe cost containment policy was followed in 
health care as a reaction to rapidly increasing health care expenditures. In table 5.4 the results of 
the conditional ECM are given for the period 1980-2003. The impact of GDP and the age 
structure of the population do not differ much compared to 1970-2003. The impact of the oldest 
age group seems somewhat higher. Because of the limited number of observations we have to 
be careful drawing conclusions about the difference in periods. The results seem to suggest that 
an increase in the relative price of health care has somewhat less long-run impact on real health 
care expenditures in the period of cost containment. A possible explanation for decreasing the 
volume of health care to a larger extent is that more emphasis will be put on staying within a 
budget. If relative price increases can not be prevented, decreasing the volume of care can serve 
as an alternative in a period where cost containment is an important policy goal. 
Developments in the public share of financing on the other hand have an almost significant 
positive effect on real health care expenditures in the cost containment period, while for 1970-
2003 no significant effect could be found. In 6 of the 8 countries under consideration the share 
of public financing decreased between 1980 and 2003. Possibly this decrease in the share of 
public financing is only partly compensated by an  increase in private expenditures on health 
care, meaning that total health care expenditures drop.  
Table 5.4  Estimation results ECM long run  1980-2003 
Variable  Coefficient  Standard Error  T-statistic 
       
log (GDP)   0.961  0.053  18.05 
log (POP65_74)   0.297  0.115  2.57 
log (POP75)   0.583  0.095  6.15 
log (PUBLIC)    0.220  0.120  1.82 
log (PRICE)  0.431  0.214  2.01 
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6  Conclusions 
Based on a study of the literature on international health care expenditures we extend the 
macro-model with the factor relative prices of health care. In order to test the impact of relative 
prices we construct a time series. Furthermore, we use an error correction model to gain more 
insight into short run and long run dynamics of the driving factors of health care expenditures. 
The estimation results suggest that there is a stable long run relationship between health care 
expenditures on the one hand and GDP, age structure of the population  and the relative price of 
health care on the other hand. In the short run, the growth of health care expenditures is mainly 
affected by changes in the relative price and changes in the share of public financing. The speed 
of adjustment to the long run equilibrium differs considerably among the countries considered. 
For some countries the effects of a temporary shock in one of the drivers of the health care 
expenditures takes a long time to die out. Given the direct and long run effects, the conclusion 
seems justified that the effect of the relative price should be taken into account in modelling 
health care expenditures. 
For the relative price of health care our conclusions are the following. The relative price has 
a significant impact on health care expenditures in the long run and for most countries -among 
which the Netherlands - also in the short run. We find coefficients which imply that an increase 
in price decreases volume and increases real health care expenditures in the long run. 
Furthermore, the estimation results, though uncertain, suggest that the impact of the price was 
larger (in absolute value) during the period 1980-2003. This could be explained by the strong 
cost containment policy during this period, in which budgets are fixed and prices have less 
influence on expenditures. As more observations are needed to draw robust conclusions, further 
research is needed on this point.  
It is conceivable that price elasticities will change when health care markets develop to more 
demand-driven systems. Moreover, a more competitive health care market will lead to market 
prices instead of the current mostly regulated prices. These market prices of health care may 
contribute to the reliability of future research on relative prices. Another possible future 
development is that the Baumol effect will become less important in the health care sector as 
incentives for efficiency and shortages in the labour market start to play a larger role. These 
shortages will presumably lead to greater effort to increase labour productivity, since additional 
personnel is difficult to find. 
With respect to the other explanatory variables used in our models, we briefly summarize 
the long run results. Consistent with most recent findings in the literature we find that income 
and ageing are important drivers of health care expenditures. The income elasticity is  
significantly positive and just below unity. It takes values of 0.93 and 0.96, which corresponds 
well to the existing literature. Estimating models for the time period 1980-2003 instead of 1970-
2003 results in comparable income elasticities. Ageing turns out to have a positive impact on 
health care expenditures, while both the coefficients of the population aged between 65 and 74   32 
and the population aged above 75 are significantly positive. This may partly be explained by the 
high costs of dying, which is proxied by the age composition.  For the public share of health 
care the results are more uncertain.   33 
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Appendix A   List of variables 
 
HCE           :  real health care expenditures per capita 
GDP           :  real gross domestic product per capita 
PRICE        :  relative price of health care 
POP65_74  :  population aged 65-74 as share of total population 
POP75        :  population aged 75+ as share of total population 
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Appendix B   Construction of relative prices 
To create time series for the relative price of health care for the old  EU-15 countries, we need 
series for the price of health care and series for the gdp-price. However, there is a lack of good 
data concerning the price of health care. Therefore we have constructed the price of health care 
from macro series for wages and prices (a consumer price index), in the following way
5: 
 
Price health = wages^α * prices^(1-α)                                                                                     (b.1) 
  
Hence, the price of health care can be said to be constructed as a weighted average of wages 
and prices. We have determined the weights making use of the national accounts for all 
countries. From the national accounts we have collected data on the total production, total 
intermediate consumption (supplied by other sectors), total value added and compensation for 
employees of the health and social work services sector.
6  For each country the weight for 
wages is determined as
7: 
 
α = (wages + social premiums + 2/3* total intermediate consumption) / production              (b.2) 
 
Hence, the weight is defined as the compensation for employees in the health care sector plus 
the estimated compensation for employees in the intermediate consumption part (for this we use 
an estimated wage share of 2/3) divided by total production. 
After determining the weights in this way, we have calculated the price of health care for all 
countries, making use of formula b.1. For wages we have used the nominal compensation per 
employee index and for prices we haven taken the national consumer price index (cpi), both 
from the AMECO database.
8 Hence, equation (b.1) can be written as  
 
price health=(nominal compensation per employee index)^α *(national consumer price    






5 We implicitly assume that labour productivity growth in health care is 0. 
6 Total production consists of the intermediate consumption and total value added. 
7 We have decided to keep α constant for each country, since this parameter hardly changes over time. 
8 http://europa.eu.int/comm/economy_finance/indicators/annual_macro_economic_database/ameco_en.htm  